[{"Assets_0_Q3_USD":"9834866000.0","CIK":"1593034","CommonStockSharesConverted_0_Q3_shares":"226763072.0","CommonStockSharesOutstanding_0_Q3_shares":"226763072.0","Country":"Ireland","EarningsPerShareBasic_1_Q3_USD":"-0.35","EarningsPerShareBasic_3_Q3_USD":"-0.9","EarningsPerShareDiluted_1_Q3_USD":"-0.35","EarningsPerShareDiluted_3_Q3_USD":"-0.9","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"640358301.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"119244000.0","NetIncomeLossConverted_1_Q3_USD":"-79415000.0","NetIncomeLossConverted_3_Q3_USD":"-203993000.0","OfficialName":"Endo International plc Ordinary Shares","RevenuesConverted_1_Q3_USD":"729426000.0","RevenuesConverted_3_Q3_USD":"2149564000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"-661477000.0","Ticker":"ENDP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"226598000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"225804000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"226598000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"225804000.0","filed":"20191104","footnote":null,"form":"10-Q","fp":"Q3","fy":"2019.0","name":"ENDO INTERNATIONAL PLC","period":"20190930","qtrs":"0","uom":"USD"}]